|
1
|
National Cancer Institute (NCI). Cancer of
unknown primary-health professional version. National Cancer
Institute, 2017. https://www.cancer.gov/types/unknown-primary/hp.
|
|
2
|
Pavlidis N and Pentheroudakis G: Cancer of
unknown primary site. Lancet. 379:1428–1435. 2012.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Rassy E, Parent P, Lefort F, Boussios S,
Baciarello G and Pavlidis N: New rising entities in cancer of
unknown primary: Is there a real therapeutic benefit? Crit Rev
Oncol Hematol. 147(102882)2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Schaffer AL, Pearson SA, Dobbins TA, Er
CC, Ward RL and Vajdic CM: Patterns of care and survival after a
cancer of unknown primary (CUP) diagnosis: A population-based
nested cohort study in Australian government department of
Veterans' Affairs clients. Cancer Epidemiol. 39:578–584.
2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Moran S, Martinez-Cardús A, Boussios S and
Esteller M: Precision medicine based on epigenomics: The paradigm
of carcinoma of unknown primary. Nat Rev Clin Oncol. 14:682–694.
2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
American Cancer Society (ACS). Key
statistics for pancreatic cancer. American Cancer Society, 2020.
https://www.cancer.org/cancer/pancreatic-cancer/about/key-statistics.html#references.
|
|
7
|
Henrikson NB, Aiello Bowles EJ, Blasi PR,
Morrison CC, Nguyen M, Pillarisetty VG and Lin JS: Screening for
pancreatic cancer: Updated evidence report and systematic review
for the US preventive services task force. JAMA. 322:445–454.
2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Khalaf N, El-Serag HB, Abrams HR and
Thrift AP: Burden of pancreatic cancer: From epidemiology to
practice. Clin Gastroenterol Hepatol. 19:876–884. 2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zhang Q, Zeng L, Chen Y, Lian G, Qian C,
Chen S, Li J and Huang K: Pancreatic cancer epidemiology,
detection, and management. Gastroenterol Res Pract.
2016(8962321)2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Sève P, Mackey J, Sawyer M, Lesimple T, de
La Fouchardière C, Broussolle C, Dumontet C and Ray-Coquard I:
Impact of clinical practice guidelines on the management for
carcinomas of unknown primary site: A controlled ‘before-after’
study. Bull Cancer. 96:E7–E17. 2009.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Pentheroudakis G, Stahel R, Hansen H and
Pavlidis N: Heterogeneity in cancer guidelines: Should we eradicate
or tolerate? Ann Oncol. 19:2067–2078. 2008.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Smith-Gagen J, Drake CM, White LL and
Pinheiro PS: Extent of diagnostic inquiry among a population-based
cohort of patients with cancer of unknown primary. Cancer Rep Rev.
3:2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Klabunde CN, Warren JL and Legler JM:
Assessing comorbidity using claims data: An overview. Med Care. 40
(8 Suppl):IV26–IV35. 2002.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Department of Health Pharmaceutical
Oncology Initiative (DHPOI). The impact of patient age on clinical
decision-making in oncology. London, UK: Department of Health,
2012.
|
|
15
|
Massarweh NN, Park JO, Bruix J, Yeung RS,
Etzioni RB, Symons RG, Baldwin LM and Flum DR: Diagnostic imaging
and biopsy use among elderly medicare beneficiaries with
hepatocellular carcinoma. J Oncol Pract. 7:155–160. 2011.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Schaffer AL, Pearson SA, Perez-Concha O,
Dobbins T, Ward RL, van Leeuwen MT, Rhee JJ, Laaksonen MA, Craigen
G and Vajdic CM: Diagnostic and health service pathways to
diagnosis of cancer-registry notified cancer of unknown primary
site (CUP). PLoS One. 15(e0230373)2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Jones W, Allardice G, Scott I, Oien K,
Brewster D and Morrison DS: Cancers of unknown primary diagnosed
during hospitalization: A population-based study. BMC Cancer.
17(85)2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Rassy E and Pavlidis N: The currently
declining incidence of cancer of unknown primary. Cancer Epidemiol.
61:139–141. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Pavlidis N, Rassy E and Smith-Gagen J:
Cancer of unknown primary: Incidence rates, risk factors and
survival among adolescents and young adults. Int J Cancer.
146:1490–1498. 2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Noel M and Fiscella K: Disparities in
pancreatic cancer treatment and outcomes. Health Equity. 3:532–540.
2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Tavakkoli A, Singal AG, Waljee AK,
Elmunzer BJ, Pruitt SL, McKey T, Rubenstein JH, Scheiman JM and
Murphy CC: Racial disparities and trends in pancreatic cancer
incidence and mortality in the United States. Clin Gastroenterol
Hepatol. 18:171–178.e10. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Zhou H, Zhang Y, Wei X, Yang K, Tan W, Qiu
Z, Li S, Chen Q, Song Y and Gao S: Racial disparities in pancreatic
neuroendocrine tumors survival: A SEER study. Cancer Med.
6:2745–2756. 2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Federal Interagency Forum (FIF) on
Aging-Related Statistics. Older Americans: Key indicators of
well-being. U.S. Government Printing Office, 2015.
|
|
24
|
Rassy E, Labaki C, Chebel R, Boussios S,
Smith-Gagen J, Greco FA and Pavlidis N: Systematic review of the
CUP trials characteristics and perspectives for next-generation
studies. Cancer Treat Rev. 107(102407)2022.PubMed/NCBI View Article : Google Scholar
|
